OneSource Specialty Pharma Declines 5.70%: Bearish Signals Dominate Amid Technical Downturn

1 hour ago
share
Share Via
OneSource Specialty Pharma Ltd experienced a challenging week, with its stock price declining 5.70% from ₹1,601.00 to ₹1,509.75, underperforming the Sensex’s 3.20% fall over the same period. The week was marked by a series of bearish technical developments, including a shift to sideways momentum, the formation of a Death Cross, and a sustained bearish trend confirmed by multiple indicators. These events collectively signalled growing investor caution amid deteriorating price momentum and fundamental concerns.

Key Events This Week

28 Sep: Stock closes at ₹1,566.50 after a 2.15% decline amid technical momentum shift

29 Sep: Technical momentum shifts to sideways with mixed signals; stock closes at ₹1,584.40 (+1.14%)

30 Sep: Death Cross formation signals bearish trend; stock drops 3.72% to ₹1,525.45

1 Oct: Bearish momentum intensifies; stock declines 1.03% to ₹1,509.75

Week Open
₹1,601.00
Week Close
₹1,509.75
-5.70%
Week High
₹1,601.00
Sensex Change
-3.20%

28 September: Technical Momentum Shift Amid Mixed Market Signals

OneSource Specialty Pharma Ltd opened the week on a weak note, closing at ₹1,566.50, down 2.15% from the previous close of ₹1,601.00. This decline occurred alongside a broader market sell-off, with the Sensex falling 1.60% to 34,788.97. Technical indicators revealed a shift from a mildly bullish trend to sideways momentum, reflecting uncertainty among investors. The weekly MACD and KST indicators turned bearish, while daily moving averages remained mildly bullish, suggesting short-term support but longer-term caution. The stock traded within a narrow range, well below its 52-week high of ₹1,924.00 but comfortably above its 52-week low of ₹1,075.00.

29 September: Mixed Signals as Stock Recovers Slightly

The stock rebounded modestly on 29 September, gaining 1.14% to close at ₹1,584.40, outperforming the Sensex which declined 0.48% to 34,621.52. Despite this uptick, technical momentum remained mixed. The sideways trend persisted, with neutral RSI readings and bearish weekly MACD and KST indicators. The MarketsMOJO Mojo Score stood at 47.0, categorising the stock as a Sell, reflecting the deteriorating technical outlook. This day’s price action suggested a tentative pause in selling pressure but no clear reversal of the bearish trend.

While markets shift, this one's charging ahead! This Micro Cap from Aquaculture shows the strongest momentum signals in current conditions. Don't miss out on this ride!

  • - Strongest current momentum
  • - Market-cycle outperformer
  • - Aquaculture sector strength

Don't Miss This Ride →

30 September: Death Cross Formation Signals Bearish Trend

The technical outlook worsened significantly on 30 September as OneSource Specialty Pharma Ltd formed a Death Cross, with the 50-day moving average crossing below the 200-day moving average. This is a widely recognised bearish signal indicating potential sustained downward momentum. The stock price fell sharply by 3.72% to ₹1,525.45, underperforming the Sensex’s marginal 0.17% decline to 34,564.37. Other technical indicators, including bearish weekly MACD and Bollinger Bands, confirmed the negative trend. The company’s negative price-to-earnings ratio of -485.01 and a Mojo Score of 47.0 reinforced concerns about fundamental weakness. The stock’s one-year performance lagged the Sensex by a wide margin, declining 16.84% versus the Sensex’s 9.70% fall.

1 October: Bearish Momentum Intensifies Amid Technical Downturn

On 1 October, the bearish trend continued with the stock declining a further 1.03% to close at ₹1,509.75, while the Sensex dropped 0.99% to 34,221.41. Technical indicators confirmed a decisive shift to a bearish trend, with daily moving averages turning negative and weekly MACD and KST indicators signalling increasing selling pressure. Bollinger Bands on weekly and monthly charts showed heightened downside volatility. Despite mildly bullish volume indicators, the lack of price strength suggested limited buying interest. The downgrade to a Sell rating by MarketsMOJO on 28 September aligned with these developments, underscoring the stock’s vulnerability. The stock’s relative underperformance against the Sensex over the week and year-to-date highlighted ongoing challenges.

Is OneSource Specialty Pharma Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!

  • - Better alternatives suggested
  • - Cross-sector comparison
  • - Portfolio optimization tool

Find Better Alternatives →

Daily Price Performance vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-09-28 ₹1,566.50 -2.15% 34,788.97 -1.60%
2026-09-29 ₹1,584.40 +1.14% 34,621.52 -0.48%
2026-09-30 ₹1,525.45 -3.72% 34,564.37 -0.17%
2026-10-01 ₹1,509.75 -1.03% 34,221.41 -0.99%

Key Takeaways

Bearish Technical Signals Dominate: The week was characterised by a clear shift from sideways to bearish momentum, highlighted by the Death Cross formation and bearish MACD and KST indicators. These signals suggest sustained downward pressure on the stock price in the near to medium term.

Underperformance Relative to Sensex: OneSource Specialty Pharma Ltd declined 5.70% over the week, significantly underperforming the Sensex’s 3.20% fall. This relative weakness reflects both company-specific challenges and broader sector headwinds.

Fundamental Concerns Persist: The company’s deeply negative P/E ratio and downgrade to a Sell rating by MarketsMOJO underscore ongoing fundamental weaknesses. The stock’s one-year and year-to-date performance lag the broader market, signalling structural challenges.

Volume Indicators Mixed: Mildly bullish On-Balance Volume readings suggest some accumulation, but this has not translated into price strength, indicating cautious investor sentiment.

Support and Resistance Levels: Key support near ₹1,560 was breached during the week, with resistance around ₹1,600 to ₹1,620 remaining a hurdle for any recovery attempts.

Conclusion

OneSource Specialty Pharma Ltd’s week was marked by a pronounced deterioration in technical momentum, culminating in a 5.70% decline and a clear bearish trend. The formation of the Death Cross and confirmation from multiple technical indicators signal that the stock is facing sustained selling pressure. Despite some volume-based hints of accumulation, the lack of price recovery and the downgrade to a Sell rating reflect a cautious outlook. Relative underperformance against the Sensex and fundamental concerns further compound the challenges. Investors should monitor key technical levels and sector developments closely, as the stock remains vulnerable to further downside in the near term.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News